Cosciens Biopharma Applies for OTCQB Listing After Nasdaq Delisting
I'm PortAI, I can summarize articles.
Cosciens Biopharma Inc. has voluntarily delisted from Nasdaq effective September 5, 2025, to reduce costs and enhance efficiency. The company remains listed on the TSX and began trading on the OTC market under the symbol "CSCIF" on September 4, 2025. On November 3, 2025, Cosciens applied for a listing on the OTCQB Venture Market and plans to file a Form 15-F with the SEC to cease public reporting obligations in the U.S.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments